18.59
전일 마감가:
$18.95
열려 있는:
$18.17
하루 거래량:
633.07K
Relative Volume:
0.66
시가총액:
$576.23M
수익:
$17.16M
순이익/손실:
$-163.62M
주가수익비율:
-3.0576
EPS:
-6.08
순현금흐름:
$-121.61M
1주 성능:
-0.64%
1개월 성능:
+10.52%
6개월 성능:
-44.51%
1년 성능:
-17.45%
Anaptysbio Inc Stock (ANAB) Company Profile
명칭
Anaptysbio Inc
전화
858-362-6295
주소
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA
ANAB을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
ANAB
Anaptysbio Inc
|
18.59 | 576.23M | 17.16M | -163.62M | -121.61M | -6.08 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
484.82 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
634.23 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
591.87 | 36.10B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
270.02 | 35.03B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
272.17 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Anaptysbio Inc Stock (ANAB) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-02-04 | 개시 | Wolfe Research | Outperform |
2024-12-11 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
2024-12-02 | 다운그레이드 | BTIG Research | Buy → Neutral |
2024-07-22 | 개시 | H.C. Wainwright | Buy |
2024-07-19 | 업그레이드 | JP Morgan | Neutral → Overweight |
2024-04-16 | 개시 | Leerink Partners | Outperform |
2024-04-11 | 개시 | Wells Fargo | Overweight |
2024-03-12 | 업그레이드 | Wedbush | Neutral → Outperform |
2024-02-26 | 개시 | BTIG Research | Buy |
2024-02-21 | 개시 | Stifel | Buy |
2024-02-16 | 개시 | Piper Sandler | Overweight |
2023-05-22 | 업그레이드 | JP Morgan | Underweight → Neutral |
2023-05-18 | 개시 | TD Cowen | Outperform |
2023-01-06 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
2022-11-01 | 업그레이드 | Guggenheim | Neutral → Buy |
2022-09-19 | 재개 | H.C. Wainwright | Buy |
2022-09-13 | 다운그레이드 | Truist | Buy → Hold |
2022-09-01 | 개시 | Raymond James | Outperform |
2022-03-22 | 다운그레이드 | Guggenheim | Buy → Neutral |
2021-06-22 | 개시 | H.C. Wainwright | Buy |
2021-05-21 | 개시 | UBS | Neutral |
2021-03-16 | 업그레이드 | Truist | Hold → Buy |
2021-03-09 | 다운그레이드 | Wedbush | Outperform → Neutral |
2021-03-08 | 다운그레이드 | JP Morgan | Overweight → Underweight |
2021-02-11 | 업그레이드 | JP Morgan | Underweight → Overweight |
2020-10-27 | 업그레이드 | Wedbush | Neutral → Outperform |
2020-10-14 | 업그레이드 | Guggenheim | Neutral → Buy |
2019-11-08 | 다운그레이드 | JP Morgan | Overweight → Underweight |
2019-11-08 | 다운그레이드 | Jefferies | Buy → Hold |
2019-11-08 | 다운그레이드 | SunTrust | Buy → Hold |
2019-11-08 | 다운그레이드 | Wedbush | Outperform → Neutral |
2019-06-21 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
2019-06-21 | 다운그레이드 | Stifel | Buy → Hold |
2018-12-20 | 개시 | H.C. Wainwright | Buy |
2018-11-21 | 개시 | JP Morgan | Overweight |
2018-07-19 | 개시 | Credit Suisse | Outperform |
2018-04-04 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
2018-03-27 | 재확인 | Stifel | Buy |
2018-03-06 | 재확인 | Stifel | Buy |
2018-02-15 | 재확인 | SunTrust | Buy |
2018-01-23 | 재확인 | Credit Suisse | Outperform |
2017-11-15 | 개시 | SunTrust | Buy |
2017-11-09 | 개시 | Jefferies | Buy |
2017-10-11 | 재확인 | RBC Capital Mkts | Outperform |
2017-09-15 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Anaptysbio Inc 주식(ANAB)의 최신 뉴스
AnaptysBio (NASDAQ:ANAB) Trading Up 2.5%What's Next? - MarketBeat
How to Take Advantage of moves in (ANAB) - news.stocktradersdaily.com
AnaptysBio (NASDAQ:ANAB) Shares Gap UpShould You Buy? - MarketBeat
Charles Schwab Investment Management Inc. Acquires 5,733 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
AnaptysBio (NASDAQ:ANAB) Trading Down 4.1%Should You Sell? - MarketBeat
AnaptysBio (NASDAQ:ANAB) to Repurchase $75.00 million in Stock - MarketBeat
Leerink Partners Sticks to Their Buy Rating for AnaptysBio (ANAB) - The Globe and Mail
AnaptysBio, Inc. (NASDAQ:ANAB) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
AnaptysBio (ANAB) Moves 9.5% Higher: Will This Strength Last? - MSN
AnaptysBio (NASDAQ:ANAB) to Repurchase $75.00 million in Shares - Defense World
AnaptysBio Shares Jump on Buyback Program Authorization - MarketWatch
Crude Oil Gains 1%; US Composite PMI Surges In March - Benzinga
Anaptys Announces Stock Repurchase Plan - GlobeNewswire
AnaptysBio authorizes $75 million stock buyback plan By Investing.com - Investing.com South Africa
Anaptys announces $75 million stock repurchase plan - MSN
AnaptysBio Announces $75 Mln Stock Repurchase Plan - Nasdaq
AnaptysBio stock rises following stock repurchase plan By Investing.com - Investing.com Canada
Intuitive Machines Posts Q4 Results, Joins Tesla, AnaptysBio, Coherent And Other Big Stocks Moving Higher On Monday - Benzinga
AnaptysBio Approves $75 Million Buyback Plan; Shares Rise -March 24, 2025 at 09:50 am EDT - Marketscreener.com
AnaptysBio authorizes $75 million stock buyback plan - Investing.com India
AnaptysBio, Inc. Authorizes $75 Million Stock Repurchase Plan - Nasdaq
AnaptysBio (NASDAQ:ANAB) Stock Price Up 4.4%What's Next? - MarketBeat
AnaptysBio, Inc. (NASDAQ:ANAB) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
AlphaQuest LLC Purchases 4,237 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
AnaptysBio, Inc. (NASDAQ:ANAB) Position Raised by Victory Capital Management Inc. - MarketBeat
Victory Capital Management Inc. Purchases 97,200 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
Wells Fargo Predicts Up to ~440% Rally for These 2 ‘Strong Buy’ Stocks - Markets Insider
AnaptysBio (NASDAQ:ANAB) Price Target Raised to $42.00 - MarketBeat
Rhumbline Advisers Grows Position in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
HC Wainwright Reaffirms Neutral Rating for AnaptysBio (NASDAQ:ANAB) - MarketBeat
When (ANAB) Moves Investors should Listen - Stock Traders Daily
Y Intercept Hong Kong Ltd Purchases Shares of 23,497 AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat
AnaptysBio (NASDAQ:ANAB) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - Defense World
Leerink Partnrs Weighs in on AnaptysBio FY2029 Earnings - MarketBeat
AnaptysBio (ANAB) to Release Quarterly Earnings on Monday - MarketBeat
AnaptysBio: A Shadow Of Its Former Self (NASDAQ:ANAB) - Seeking Alpha
Palmoplantar Pustulosis Clinical and Non-Clinical Studies, - openPR
AnaptysBio’s (ANAB) Neutral Rating Reaffirmed at HC Wainwright - Defense World
AnaptysBio, Inc. (NASDAQ:ANAB) Short Interest Update - MarketBeat
AnaptysBio (NASDAQ:ANAB) Shares Gap Up Following Strong Earnings - MarketBeat
H.C. Wainwright maintains AnaptysBio stock Neutral with $22 target By Investing.com - Investing.com Canada
Anaptysbio Inc (ANAB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):